TYLER FERNANDES: Open Payments
NPI 1083376578 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,032 in 56 payments from 7 companies in 2025. Trend: 2023 $6,255 · 2024 $3,519 · 2025 $2,032
Food & beverage: $2,032
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 23 | $1,092 |
| Gilead Sciences, Inc. | 12 | $361 |
| ABBVIE INC. | 10 | $265 |
| Axsome Therapeutics, Inc. | 6 | $205 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Lilly USA, LLC | 1 | $18 |
Products named: APRETUDE, VRAYLAR, CABENUVA, DOVATO, Yeztugo, Symbravo, RUKOBIA, Auvelity.
Industry payments across NJ — which companies pay providers there.
